诊断影像市场 - 全球产业规模、份额、趋势、机会和预测，按产品、应用、最终用途、地区和竞争细分，2020-2030 年预测

2024 年全球诊断影像市场价值为 270.1 亿美元，预计到 2030 年将达到 363.9 亿美元，预测期内复合年增长率为 5.05%。全球诊断影像市场主要受技术进步、医疗保健需求成长和人口老化所推动。人工智慧 (AI) 整合、3D 成像和微创手术等创新正在提高诊断成像的准确性和效率，使其更易于获取和更有效。癌症、心血管疾病和神经系统疾病等慢性疾病的发生率不断上升，推动了对早期和准确诊断的需求。新兴市场医疗保健基础设施的不断增长，以及人们对早期疾病检测益处的认识的不断提高，进一步支持了市场的成长。政府对医疗保健的投资和数位健康解决方案的日益采用促进了全球诊断成像市场的全面扩张。

市场概况
预测期	2026-2030
2024 年市场规模	270.1 亿美元
2030 年市场规模	363.9 亿美元
2025-2030 年复合年增长率	5.05％
成长最快的领域	X 射线
最大的市场	北美洲

主要市场驱动因素

成像设备的技术进步

慢性病盛行率上升

医疗支出不断上涨

人口老化

提高早期疾病检测意识

政府措施和医疗改革

主要市场挑战

先进成像设备成本高昂

专业技能人才短缺

主要市场趋势

微创手术需求不断成长

成像与其他医疗系统的集成

分段洞察

产品洞察

最终用途洞察

区域洞察

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：顾客之声

第五章：全球诊断影像市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 副产品（X 光、超音波、电脑断层扫描、核子造影和磁振造影）
  • 依应用（肿瘤科、神经科、心臟科、妇科、骨科及其他）
  • 依最终用途（医院、诊断影像中心和门诊影像中心）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第 6 章：北美诊断影像市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按产品
  • 按应用
  • 按最终用途
  • 按国家
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第 7 章：欧洲诊断影像市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按产品
  • 按应用
  • 按最终用途
  • 按国家
• 欧洲：国家分析
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙

第 8 章：亚太地区诊断影像市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按产品
  • 按应用
  • 按最终用途
  • 按国家
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第 9 章：南美洲诊断影像市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按产品
  • 按应用
  • 按最终用途
  • 按国家
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲诊断影像市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按产品
  • 按应用
  • 按最终用途
  • 按国家
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购（如有）
• 产品发布（如果有）
• 最新动态

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 14 章：竞争格局

• GE HealthCare Technologies Inc.
• Koninklijke Philips NV
• Hitachi High-Tech Corporation
• Hologic, Inc.
• Siemens Healthineers AG
• Samsung Medicine Co., Ltd.
• Shimadzu Corporation
• Toshiba Medical Systems Corporation
• Esaote SpA
• Fujifilm Corporation

第 15 章：策略建议

第16章 调査会社について・免责事项

Global Diagnostic Imaging Market was valued at USD 27.01 Billion in 2024 and is expected to reach USD 36.39 Billion by 2030 with a CAGR of 5.05% during the forecast period. The global diagnostic imaging market is primarily driven by advancements in technology, rising healthcare needs, and an aging population. Innovations such as artificial intelligence (AI) integration, 3D imaging, and minimally invasive procedures are enhancing the accuracy and efficiency of diagnostic imaging, making it more accessible and effective. The increasing prevalence of chronic diseases like cancer, cardiovascular conditions, and neurological disorders is driving demand for early and accurate diagnostics. Growing healthcare infrastructure in emerging markets, along with rising awareness about the benefits of early disease detection, further supports market growth. Government investments in healthcare and the increasing adoption of digital health solutions contribute to the overall expansion of the diagnostic imaging market globally.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 27.01 Billion
Market Size 2030	USD 36.39 Billion
CAGR 2025-2030	5.05%
Fastest Growing Segment	X-Ray
Largest Market	North America

Key Market Drivers

Technological Advancements in Imaging Equipment

Technological innovation remains the backbone of the global diagnostic imaging market. Over the years, diagnostic imaging technologies have made remarkable strides, significantly impacting the quality and efficiency of medical diagnostics. One of the most notable advances is the integration of artificial intelligence (AI) and machine learning algorithms into diagnostic imaging. AI-enabled devices can assist radiologists in interpreting images more quickly and accurately by detecting patterns that may be challenging to spot by the human eye. Machine learning algorithms can process vast amounts of data from images, leading to faster diagnoses and better treatment outcomes.

In addition to AI, developments in 3D imaging and augmented reality (AR) are allowing for more detailed and immersive imaging. For example, 3D imaging techniques provide radiologists with a comprehensive understanding of complex anatomical structures, helping them to make more accurate diagnoses. Augmented reality is increasingly being used in medical imaging to enhance visualization during surgeries, allowing for real-time guidance based on detailed scans. In October 2022, Philips launched ClarifEye, an Augmented Reality (AR) surgical navigation solution in Japan. The company highlighted the successful outcomes of the first patients treated using the technology at the International University of Health and Welfare, Mita Hospital in Tokyo, Japan.

Another breakthrough in imaging technology is the transition from analog to digital systems. Digital imaging offers many advantages, such as higher image resolution, enhanced image storage and retrieval, and the ability to share images electronically across health systems. Digital systems reduce the time and costs associated with film development, providing a significant operational advantage for hospitals and clinics.

Portable and point-of-care diagnostic imaging devices have also emerged as a game-changer, particularly in remote or underserved areas. Devices like handheld ultrasound machines and mobile MRI scanners allow healthcare providers to deliver diagnostic services in rural and resource-constrained settings, expanding access to advanced imaging and improving patient care globally.

These technological advancements in imaging systems are not just improving diagnosis; they are also helping reduce patient exposure to radiation, particularly in modalities like CT and X-ray. Newer technologies, such as digital X-rays and low-dose CT scans, deliver high-quality images at reduced radiation levels, aligning with the growing emphasis on patient safety. The incorporation of cutting-edge technologies has paved the way for faster, more accurate, and more accessible diagnostic services, driving the growth of the diagnostic imaging market.

Increase in Chronic Disease Prevalence

The global increase in chronic diseases is one of the primary drivers of the diagnostic imaging market. Chronic conditions, including cancer, cardiovascular diseases, diabetes, and neurological disorders, are becoming more prevalent due to aging populations, lifestyle changes, and environmental factors. Early detection of these conditions is crucial, as it can significantly improve treatment outcomes and reduce mortality rates. Diagnostic imaging plays an essential role in detecting and diagnosing such diseases in their early stages, leading to better prognosis and more effective management of these conditions. According to WHO, in 2021, noncommunicable diseases (NCDs) were responsible for at least 43 million deaths, accounting for 75% of all non-pandemic-related fatalities worldwide. Of these, 18 million people died from an NCD before reaching the age of 70, with 82% of these premature deaths occurring in low- and middle-income countries. Overall, 73% of all NCD-related deaths took place in these regions. Cardiovascular diseases were the leading cause of NCD deaths, responsible for at least 19 million deaths in 2021. This was followed by cancers, with 10 million deaths, chronic respiratory diseases accounting for 4 million deaths, and diabetes causing over 2 million deaths, including those from kidney disease linked to diabetes.

For example, imaging technologies like MRI and CT scans are commonly used to detect tumors in the early stages of cancer, particularly in the breast, lungs, brain, and colon. These imaging tools help clinicians assess the size, location, and spread of tumors, enabling them to develop a tailored treatment plan. In the case of cardiovascular diseases, diagnostic imaging methods like echocardiography, CT angiography, and MRI are used to visualize blood flow, detect blockages, and monitor heart function.

As the incidence of chronic diseases increases globally, the demand for diagnostic imaging services also rises. An aging global population is a key factor contributing to the growing burden of chronic diseases. As people live longer, they are more likely to develop chronic conditions, which necessitate regular imaging to monitor disease progression and evaluate treatment effectiveness.

In addition, advancements in imaging technologies have improved the ability to detect diseases at earlier, more treatable stages. This capability has led to a greater emphasis on preventive healthcare, where patients are encouraged to undergo regular screenings and diagnostic tests to detect chronic diseases before they become more severe. As awareness of the benefits of early diagnosis grows, so too does the demand for diagnostic imaging services. The rise of chronic diseases has highlighted the need for personalized medicine, and diagnostic imaging is integral to this approach. By using advanced imaging to assess the specific characteristics of a disease, healthcare providers can tailor treatment plans to the individual patient's needs. This shift toward personalized care is driving the demand for more sophisticated imaging techniques that offer precise and accurate results.

Rising Healthcare Expenditure

Rising healthcare expenditure is another critical factor contributing to the growth of the global diagnostic imaging market. Governments, private healthcare providers, and insurance companies around the world are increasing their investments in healthcare systems, particularly in diagnostic technologies. This surge in spending is driven by the growing recognition of the importance of early detection and accurate diagnosis in improving patient outcomes and reducing long-term healthcare costs.

In developed countries, rising healthcare costs have prompted governments to seek more efficient and effective ways of delivering care. Diagnostic imaging plays a key role in these efforts by enabling earlier detection of diseases, which can reduce the need for expensive treatments and hospitalizations later on. By investing in advanced imaging technologies, healthcare systems can deliver more accurate diagnoses and provide timely interventions, ultimately improving patient care and lowering overall healthcare costs.

In emerging economies, rising healthcare expenditures are fueling demand for modern diagnostic equipment, including MRI machines, CT scanners, and ultrasound devices. As these countries experience rapid economic growth, they are increasingly able to invest in healthcare infrastructure and adopt cutting-edge medical technologies. This trend is particularly evident in regions like Asia-Pacific, where the healthcare sector is expanding rapidly to meet the needs of growing populations and a rising middle class.

The adoption of diagnostic imaging is also supported by government initiatives that promote the expansion of healthcare services. For example, public health programs in many countries focus on improving access to diagnostic services, particularly in underserved regions. This investment in healthcare infrastructure boosts the demand for diagnostic imaging technologies, contributing to market growth.

The increasing emphasis on patient-centered care and personalized medicine is pushing healthcare providers to adopt advanced diagnostic imaging systems. By offering more precise imaging, these systems help healthcare professionals provide tailored treatment plans, improving patient satisfaction and outcomes. The growing recognition of the role of diagnostic imaging in achieving these goals further accelerates the market's expansion.

Aging Population

The global aging population is another significant driver of the diagnostic imaging market. As life expectancy increases, the proportion of elderly individuals worldwide is growing. According to the World Health Organization (WHO), the number of people aged 60 years and older is expected to double by 2050. This demographic shift is accompanied by an increase in age-related diseases and conditions, including arthritis, osteoporosis, neurodegenerative disorders, and cardiovascular diseases.

Elderly individuals often require frequent medical evaluations, and diagnostic imaging plays a critical role in assessing and monitoring various age-related health issues. For example, MRI and CT scans are commonly used to detect early signs of dementia, stroke, or brain tumors in elderly patients. Ultrasound and X-ray imaging are essential for diagnosing bone fractures, joint conditions, and other musculoskeletal issues that become more prevalent with age.

As the number of elderly individuals increases, so does the demand for diagnostic imaging services. Healthcare providers are investing in advanced imaging technologies to meet the needs of this growing patient population. Healthcare systems are adapting to the challenges posed by an aging population by implementing preventive care programs and early detection strategies that rely heavily on diagnostic imaging.

The aging population often requires more specialized imaging equipment tailored to the unique needs of older patients. For example, imaging systems that accommodate patients with limited mobility or those with implantable medical devices are becoming increasingly important. The growing demand for diagnostic imaging to support the elderly population is a key factor driving market growth.

Increased Awareness of Early Disease Detection

The growing awareness of the importance of early disease detection has played a vital role in driving the global diagnostic imaging market. As healthcare education and awareness campaigns have expanded, more people are seeking preventive care and screenings to identify potential health issues before they become serious. Public health initiatives focusing on early detection of conditions such as breast cancer, prostate cancer, and cardiovascular disease have contributed to the increased utilization of diagnostic imaging services.

Imaging technologies such as mammography, CT scans, and ultrasound are widely used in routine screenings for various cancers and other conditions. For instance, breast cancer screenings using mammography have become a standard part of healthcare regimens for women, particularly those over 40 years old. Similarly, cardiac imaging technologies, including echocardiography and CT angiography, are commonly used to monitor individuals at risk of heart disease. As people become more proactive about their health, the demand for diagnostic imaging continues to rise. In May 2023, Koninklijke Philips N.V. introduced the Philips CT 3500, a premium CT system designed to meet the needs of routine radiology and high-volume screening programs.

This shift toward early detection and prevention is also being supported by technological advancements that make imaging more accessible and affordable. Digital imaging systems and portable devices allow for easier access to diagnostic services, even in underserved or remote areas. This increased availability of diagnostic imaging further drives market growth, as people are more likely to undergo regular screenings when they can access high-quality imaging services conveniently and affordably.

Government Initiatives and Healthcare Reforms

Government initiatives and healthcare reforms have significantly impacted the global diagnostic imaging market. Many countries have recognized the importance of improving healthcare access and quality, leading to increased public and private investments in the healthcare sector. In particular, governments are focusing on enhancing diagnostic capabilities, recognizing that early and accurate diagnosis is essential to improving healthcare outcomes.

In some regions, governments have launched programs aimed at expanding access to diagnostic imaging, particularly in underserved areas. For example, public health initiatives may focus on providing free or low-cost diagnostic imaging services to vulnerable populations. These efforts have led to increased adoption of diagnostic imaging technologies in low- and middle-income countries, where access to advanced medical equipment was once limited.

Healthcare reforms in developed nations have emphasized the need for cost-effective and efficient healthcare delivery. Diagnostic imaging technologies, which enable early diagnosis and personalized treatment, are seen as essential tools in achieving these goals. Government funding for healthcare infrastructure, as well as incentives for healthcare providers to invest in advanced imaging equipment, are helping to fuel the growth of the diagnostic imaging market.

Key Market Challenges

High Costs of Advanced Imaging Equipment

One of the most significant challenges facing the diagnostic imaging market is the high cost associated with acquiring, installing, and maintaining advanced imaging equipment. Technologies like MRI machines, CT scanners, and PET scanners are expensive to purchase and operate. These costs can be a substantial burden for healthcare providers, particularly in low- and middle-income countries, where financial resources may be limited.

The high costs extend beyond just the initial purchase; maintenance, calibration, and repair of imaging systems require ongoing investment. For instance, MRI machines require regular servicing to ensure they remain functional and accurate. The need for highly trained technicians to operate these machines adds to operational costs.

The expense of diagnostic imaging also affects insurance coverage and patient access, as many insurance providers may limit the reimbursement for certain high-cost imaging procedures. This can lead to inequities in access to advanced diagnostic services, particularly in rural and underserved regions, creating a significant barrier to widespread adoption and use of these technologies.

Shortage of Skilled Professionals

Another challenge facing the global diagnostic imaging market is the shortage of skilled professionals, including radiologists, imaging technicians, and medical physicists. Advanced imaging systems require specialized knowledge and expertise to operate correctly, interpret results, and ensure patient safety. The demand for radiologists and technicians is increasing with the rising prevalence of chronic diseases and the growing need for diagnostic imaging services. However, there is a shortage of trained professionals to meet this demand, particularly in emerging economies.

In many countries, there is a significant gap between the number of trained imaging professionals and the growing need for diagnostic services. This shortage not only limits the availability of imaging services but can also lead to delays in diagnosis and treatment, which may affect patient outcomes. As diagnostic imaging technologies become more advanced, the need for continuous training and education for existing professionals becomes even more critical. The lack of well-trained personnel, coupled with high turnover rates in some regions, remains a significant challenge to the growth of the diagnostic imaging market.

Key Market Trends

Rising Demand for Minimally Invasive Procedures

As patients and healthcare providers continue to prioritize less invasive treatment options, the demand for minimally invasive procedures is rising. Diagnostic imaging plays a critical role in guiding these procedures, providing real-time visualization of internal structures without the need for large incisions or surgeries. Techniques such as endoscopic procedures, image-guided biopsies, and laparoscopic surgeries rely heavily on diagnostic imaging technologies like ultrasound, CT, and MRI.

The ability to perform minimally invasive procedures with the guidance of advanced imaging systems improves patient outcomes by reducing recovery times, minimizing complications, and lowering healthcare costs. As the preference for minimally invasive treatments grows, so too does the demand for the diagnostic imaging tools that support these procedures. This trend is expected to continue, further driving the global diagnostic imaging market.

Integration of Imaging with Other Medical Systems

The integration of diagnostic imaging systems with electronic health records (EHRs), clinical decision support systems (CDSS), and other healthcare technologies is enhancing the value of imaging in patient care. By connecting imaging data to broader healthcare systems, medical professionals can access comprehensive patient information in real-time, improving diagnostic accuracy and facilitating more coordinated care. In February 2023, GE Healthcare announced that it had reached an agreement to acquire the privately held AI healthcare company, Caption Health, Inc. Known for its clinical applications aimed at early disease diagnosis, Caption Health leverages AI technology to enhance ultrasound scan processes.

This integration enables better patient management, as physicians can easily track the progress of diagnoses and treatment plans across multiple specialties. The ability to share imaging data electronically enhances collaboration between healthcare providers, leading to more informed and timely decision-making. The trend toward digital health solutions and interconnected medical technologies is expected to continue driving the growth of the diagnostic imaging market, as healthcare systems increasingly rely on integrated technologies to improve patient outcomes and operational efficiency. The seamless flow of information between imaging systems and other healthcare platforms will play a key role in shaping the future of medical diagnostics.

Segmental Insights

Product Insights

Based on the product, X-ray currently dominates the global diagnostic imaging market. X-ray technology has been a cornerstone of medical diagnostics for over a century, and its widespread use across healthcare settings, from hospitals to outpatient clinics, has cemented its position as the leading imaging modality. The X-ray market benefits from its relatively low cost, speed, and accessibility, making it an essential diagnostic tool in both developed and emerging markets.

X-ray imaging is particularly prevalent in routine diagnostic procedures, including chest X-rays for pulmonary conditions, skeletal imaging for fractures, and dental radiographs. The technology's ability to quickly provide valuable information on bone fractures, infections, and some soft tissue conditions is a key driver of its dominance. X-ray systems are often found in a variety of healthcare settings, including emergency departments, diagnostic centers, and even point-of-care locations, contributing to its extensive reach. The adaptability of X-ray machines-such as the development of digital X-rays, which offer improved image quality and reduced radiation exposure-has also enhanced its value in the healthcare system.

Computed tomography (CT), which uses X-rays to produce cross-sectional images, has seen rapid growth in recent years, especially for its ability to diagnose complex conditions such as cancers, cardiovascular diseases, and trauma. However, the higher cost of CT equipment, as well as the need for specialized personnel, limits its widespread use in comparison to X-ray. While CT scans offer more detailed images, the increased radiation exposure associated with frequent CT scans has raised concerns regarding patient safety, which has slowed its growth relative to other imaging technologies. CT is mainly used in tertiary healthcare centers, where complex diagnostic needs require detailed cross-sectional imaging.

End Use Insights

Based on the end use segment, hospitals continue to dominate the global diagnostic imaging market. Hospitals are key players in the healthcare sector, serving as comprehensive care providers that utilize diagnostic imaging for a wide range of medical purposes, from routine screenings to complex diagnostic procedures and emergency interventions. The dominant position of hospitals in the diagnostic imaging market can be attributed to their large-scale infrastructure, availability of advanced imaging technologies, and the broad spectrum of services they provide.

Hospitals typically have the capacity to offer a full range of diagnostic imaging services, including X-rays, CT scans, MRIs, ultrasounds, and nuclear imaging, and they often have the resources to maintain state-of-the-art imaging equipment. With dedicated departments for radiology and imaging, hospitals are equipped to handle not only routine imaging exams but also complex procedures and emergency situations, such as trauma care or oncological diagnostics. Their ability to provide comprehensive care, including surgery, intensive care, and rehabilitation, alongside diagnostic imaging, makes them central to patient care.

Hospitals benefit from high patient volumes, especially in larger urban centers, where populations are more likely to require a wide array of diagnostic services. The multidisciplinary nature of hospitals, where specialists across various fields-such as cardiology, oncology, neurology, and orthopedics-rely heavily on imaging to support their diagnostic and treatment processes, further strengthens their role in the diagnostic imaging market. Hospitals also have the financial resources and support systems to invest in advanced imaging technologies and maintain their operations.

Regional Insights

North America dominated the global diagnostic imaging market. This dominance is primarily driven by the advanced healthcare infrastructure, high levels of healthcare expenditure, and the rapid adoption of cutting-edge diagnostic imaging technologies in the region. The United States, in particular, is the largest market for diagnostic imaging equipment, thanks to its robust healthcare system, a large number of healthcare facilities, and the presence of numerous leading imaging technology manufacturers and service providers.

In North America, hospitals, diagnostic imaging centers, and outpatient facilities are well-equipped with state-of-the-art imaging technologies, including advanced modalities like MRI, CT, PET, and ultrasound. The high demand for diagnostic imaging services in the region is driven by an aging population, the increasing prevalence of chronic diseases (such as cancer, cardiovascular diseases, and neurological disorders), and the growing emphasis on early diagnosis and preventive care. As the demand for precise and timely diagnostic services continues to rise, healthcare providers in North America are increasingly investing in advanced imaging systems to ensure accurate diagnoses and enhance patient care.

The region is also a leader in the integration of artificial intelligence (AI) into diagnostic imaging, improving both the speed and accuracy of image interpretation. AI-powered imaging solutions are being used to assist radiologists in detecting abnormalities such as tumors, fractures, and other diseases. North American healthcare systems are highly focused on improving healthcare efficiency through technological advancements, and diagnostic imaging plays a critical role in this goal. The large-scale implementation of electronic health records (EHRs) and the integration of imaging systems into these platforms have improved patient management and facilitated seamless access to imaging data, contributing to the growth of the market.

Key Market Players

• GE HealthCare Technologies Inc.
• Koninklijke Philips N.V.
• Hitachi High-Tech Corporation
• Hologic, Inc.
• Siemens Healthineers AG
• Samsung Medicine Co., Ltd.
• Shimadzu Corporation
• Toshiba Medical Systems Corporation
• Esaote S.p.A
• Fujifilm Corporation

Report Scope:

In this report, the Global Diagnostic Imaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Diagnostic Imaging Market, By Product:

• X-Ray
• Ultrasound
• Computed Tomography
• Nuclear Imaging
• Magnetic Resonance Imaging

Diagnostic Imaging Market, By Application:

• Oncology
• Neurology
• Cardiology
• Gynecology
• Orthopedics
• Others

Diagnostic Imaging Market, By End Use:

• Hospitals
• Diagnostic Imaging Centers
• Ambulatory Imaging Centers

Diagnostic Imaging Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Diagnostic Imaging Market.

Available Customizations:

Global Diagnostic Imaging market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Diagnostic Imaging Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (X-Ray, Ultrasound, Computed Tomography, Nuclear Imaging, and Magnetic Resonance Imaging)
  • 5.2.2. By Application (Oncology, Neurology, Cardiology, Gynecology, Orthopedics, and Others)
  • 5.2.3. By End Use (Hospitals, Diagnostic Imaging Centers, and Ambulatory Imaging Centers)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Diagnostic Imaging Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By End Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Diagnostic Imaging Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End Use
  • 6.3.2. Canada Diagnostic Imaging Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End Use
  • 6.3.3. Mexico Diagnostic Imaging Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End Use

7. Europe Diagnostic Imaging Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By End Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Diagnostic Imaging Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End Use
  • 7.3.2. United Kingdom Diagnostic Imaging Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End Use
  • 7.3.3. Italy Diagnostic Imaging Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End Use
  • 7.3.4. France Diagnostic Imaging Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End Use
  • 7.3.5. Spain Diagnostic Imaging Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End Use

8. Asia-Pacific Diagnostic Imaging Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By End Use
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Diagnostic Imaging Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End Use
  • 8.3.2. India Diagnostic Imaging Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End Use
  • 8.3.3. Japan Diagnostic Imaging Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End Use
  • 8.3.4. South Korea Diagnostic Imaging Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End Use
  • 8.3.5. Australia Diagnostic Imaging Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End Use

9. South America Diagnostic Imaging Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By End Use
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Diagnostic Imaging Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End Use
  • 9.3.2. Argentina Diagnostic Imaging Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End Use
  • 9.3.3. Colombia Diagnostic Imaging Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End Use

10. Middle East and Africa Diagnostic Imaging Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By End Use
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Diagnostic Imaging Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End Use
  • 10.3.2. Saudi Arabia Diagnostic Imaging Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End Use
  • 10.3.3. UAE Diagnostic Imaging Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. GE HealthCare Technologies Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Koninklijke Philips N.V.
• 14.3. Hitachi High-Tech Corporation
• 14.4. Hologic, Inc.
• 14.5. Siemens Healthineers AG
• 14.6. Samsung Medicine Co., Ltd.
• 14.7. Shimadzu Corporation
• 14.8. Toshiba Medical Systems Corporation
• 14.9. Esaote S.p.A
• 14.10. Fujifilm Corporation

15. Strategic Recommendations

16. About Us & Disclaimer